BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
RY
Royal Bank of Canada
There isn't enough reported data to score RY yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
RY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
RY's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like RY.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over RY in the historical PE scenario, which offers more potential upside but is not a forecast.
RY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $129 | -36% |
| Fair | 13x | $142 | -30% |
| Expensive | 16x | $169 | -17% |
| Current | 19x | $203 | — |
Historical ranges are pointers, not guarantees.
RY's PE is 19x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
RY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for RY, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
RY has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus RY up 23%.
RY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $10.82 | +23% |
| Q1 2026 | $10.24 | +19% |
| Q4 2025 | $9.89 | +25% |
| Q3 2025 | $9.29 | +18% |
| Q2 2025 | $8.83 | +16% |
| Q1 2025 | $8.63 | +15% |
| Q4 2024 | $7.90 | +7% |
| Q3 2024 | $7.90 | +8.5% |
RY's earnings per share have climbed steadily: $10.82 over the past year, up 23% from the year before, and higher year over year for 10 quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
RY has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus up 117% for RY.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
RY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $23.9B | +117% |
| Q1 2026 | $12.6B | +7.3% |
| Q4 2025 | $12.1B | -49% |
| Q3 2025 | $11.9B | +16% |
| Q2 2025 | $11B | +11% |
| Q1 2025 | $11.8B | +24% |
| Q4 2024 | $23.8B | +160% |
| Q3 2024 | $10.3B | +1% |
RY's revenue is growing: $23.9B last quarter, up 117% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 21% | -14 points |
| Q1 2026 | 41% | +2.8 points |
| Q4 2025 | 40% | +24 points |
| Q3 2025 | 40% | +3.7 points |
| Q2 2025 | 35% | +0.4 points |
| Q1 2025 | 38% | +6.2 points |
| Q4 2024 | 15% | -16 points |
| Q3 2024 | 37% | +4.7 points |
RY's operating margin was 21% last quarter, down 14 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
RY Free Cash Flow
RY and BAC do not have enough comparable growth data to identify a winner.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over RY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
RY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -8.6M shares |
| 1 year | -1.4% | -20.2M shares |
| 3 years | +0.2% | +3.2M shares |
| 5 years | -2.4% | -33.8M shares |
| Available history | -2.8% | -39.7M shares |
RY has 1.4B diluted shares, down 1.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $3.5B |
| Q4 2024 | $1.5B |
| Q4 2022 | $810.6M |
| Q3 2022 | $1B |
| Q2 2022 | $1B |
| Q1 2022 | $1.2B |
| Q4 2021 | $841.5M |
| Q3 2021 | $1.1B |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
RY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 10.6x | High |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | 28.8x | High |
| Q3 2024 | -1.9x | Net Cash |
RY's net debt is about 11 years of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like RY.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
RY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.7 | Neutral |
| Stochastic | 45.9 | Neutral |
RY's weekly RSI is 56 (neutral) and its Stochastic is 46 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over RY on valuation relative to its sector.
RY PE vs Financial Services Sector
| Metric | RY | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 13x | 44% above |
| PE % | 97 | 63 | 34 pts above |
RY is trading at 19x earnings, a 44% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
RY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $199.4 | 1.6% above |
| 20 week MA | $205.1 | 1.2% below |
| 50 week MA | $187.0 | 8.4% above |
| 100 week MA | $158.3 | 28% above |
| 200 week MA | $130.1 | 56% above |
RY has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
RY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $79.1 | $81.9 | +3.5% |
| 2021 | $81.9 | $104.3 | +27% |
| 2022 | $104.3 | $94.4 | -9.5% |
| 2023 | $94.4 | $101.1 | +7.2% |
| 2024 | $101.1 | $120.9 | +20% |
| 2025 | $120.9 | $171.5 | +42% |
| 2026 YTD | $171.5 | $202.6 | +18% |
RY has the edge over BAC on returns for 2026, with the stronger performance.